Poncirus trifoliata Aqueous Extract Protects Cardiomyocytes against Doxorubicin-Induced Toxicity through Upregulation of NAD(P)H Dehydrogenase Quinone Acceptor Oxidoreductase 1 DOI Creative Commons
Min‐Sun Kim, Hyo‐Kyoung Choi, Soo-Hyun Park

et al.

Molecules, Journal Year: 2023, Volume and Issue: 28(24), P. 8090 - 8090

Published: Dec. 14, 2023

Doxorubicin (DOX), an anthracycline-based chemotherapeutic agent, is widely used to treat various types of cancer; however, prolonged treatment induces cardiomyotoxicity. Although studies have been performed overcome DOX-induced cardiotoxicity (DICT), no effective method currently available. This study investigated the effects and potential mechanisms Poncirus trifoliata aqueous extract (PTA) in DICT. Changes cell survival were assessed H9c2 rat cardiomyocytes MDA-MB-231 human breast cancer cells. The C57BL/6 mice treated with DOX induce DICT vivo, alterations electrophysiological characteristics, serum biomarkers, histological features examined. PTA inhibited decrease viability but did not affect viability. Additionally, restored abnormal heart rate, R-R interval, QT ST segment cardiac hepatic toxicity indicators model. Moreover, administration protected against myocardial fibrosis apoptosis tissue expression NAD(P)H dehydrogenase quinone acceptor oxidoreductase 1 a concentration-dependent manner. In conclusion, inhibitory effect on attributable its antioxidant properties, suggesting as phytotherapeutic agent for

Language: Английский

Melatonin alleviates doxorubicin-induced cardiotoxicity via inhibiting oxidative stress, pyroptosis and apoptosis by activating Sirt1/Nrf2 pathway DOI Creative Commons
Wei Zhang, Xi Wang, Yanhong Tang

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2023, Volume and Issue: 162, P. 114591 - 114591

Published: March 23, 2023

Melatonin confers cardioprotective effects on multiple cardiovascular diseases, including doxorubicin-induced cardiomyopathy. The effectiveness of melatonin in mitigating myocardial injuries caused by Doxorubicin through enhancement mitochondrial function is already established, however, the role regulating Sirtuin-1 (Sirt1)/Nuclear factor E2-associated 2 (Nrf2) pathway lessening onset Doxorubicin-induced cardiomyopathy yet to be elucidated. To address this, H9C2 cardiomyocytes and C57BL/6 mice were employed construct vitro vivo models Dox-induced impairments, respectively. Results showed that Dox markedly evoked oxidative stress, pyroptosis apoptosis both vivo, which significantly alleviated administration. Mechanistically, attenuated downregulation Sirt1 Nrf2, inhibition Nrf2 reversed melatonin. In conclusion, our studies suggest activation Sirt1/Nrf2 underlying mechanism behind melatonin's ability curtail pyroptosis, These promising results demonstrated potential application as a treatment for cardiac injury.

Language: Английский

Citations

37

Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review DOI Open Access
Nilesh Kumar Sharma, Anjali Bahot,

Gopinath Sekar

et al.

Cancers, Journal Year: 2024, Volume and Issue: 16(4), P. 680 - 680

Published: Feb. 6, 2024

In recent years, the emergence of cancer drug resistance has been one crucial tumor hallmarks that are supported by level genetic heterogeneity and complexities at cellular levels. Oxidative stress, immune evasion, metabolic reprogramming, overexpression ABC transporters, stemness among several key contributing molecular response mechanisms. Topo-active drugs, e.g., doxorubicin topotecan, clinically active utilized extensively against a wide variety human tumors often result in development failure to therapy. Thus, there is an urgent need for incremental comprehensive understanding mechanisms specifically context topo-active drugs. This review delves into intricate mechanistic aspects these intracellular extracellular explores use potential combinatorial approaches utilizing various drugs inhibitors pathways involved resistance. We believe this will help guide basic scientists, pre-clinicians, clinicians, policymakers toward holistic interdisciplinary strategies transcend resistance, renewing optimism ongoing battle cancer.

Language: Английский

Citations

15

Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms DOI
Xiaofeng Li

Environmental Research, Journal Year: 2023, Volume and Issue: 234, P. 116504 - 116504

Published: June 24, 2023

Language: Английский

Citations

20

SIRT3 regulates mitochondrial function: A promising star target for cardiovascular disease therapy DOI Creative Commons
Qin Zhang, Siyuan Zhou, Xing Chang

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2023, Volume and Issue: 170, P. 116004 - 116004

Published: Dec. 11, 2023

Dysregulation of mitochondrial homeostasis is common to all types cardiovascular diseases. SIRT3 regulates apoptosis and autophagy, material energy metabolism, oxidative stress, inflammation, fibrosis. As an important mediator node in the network mechanisms, essential many activities. This review explains how tricarboxylic acid cycle treat A novel description impact lifestyle factors on expression from angles nutrition, exercise, temperature provided.

Language: Английский

Citations

19

Oroxylin A suppress LL-37 generated rosacea-like skin inflammation through the modulation of SIRT3-SOD2-NF-κB signaling pathway DOI

Chunmei Feng,

Haiyan Zhang, Peiru Wang

et al.

International Immunopharmacology, Journal Year: 2024, Volume and Issue: 129, P. 111636 - 111636

Published: Feb. 15, 2024

Language: Английский

Citations

5

Research progress on the role and mechanism of Sirtuin family in doxorubicin cardiotoxicity DOI
Xuan Zhang, Chaoming Huang,

Yanhong Hou

et al.

Phytomedicine, Journal Year: 2024, Volume and Issue: 129, P. 155673 - 155673

Published: April 22, 2024

Language: Английский

Citations

5

Oridonin ameliorates doxorubicin induced-cardiotoxicity via the E2F1/Sirt6/PGC1α pathway in mice DOI
Dongsheng Yu,

Jiye Li,

Yu Wang

et al.

Food and Chemical Toxicology, Journal Year: 2023, Volume and Issue: 181, P. 114050 - 114050

Published: Sept. 19, 2023

Language: Английский

Citations

3

Aerobic Exercise Attenuates Doxorubicin-Induced Cardiomyopathy by Suppressing NLRP3 Inflammasome Activation in a Rat Model DOI Open Access

Phichaya Suthivanich,

Worakan Boonhoh, Natticha Sumneang

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(17), P. 9692 - 9692

Published: Sept. 7, 2024

Doxorubicin (DOX) is a potent chemotherapeutic agent with well-documented dose-dependent cardiotoxicity. Regular exercise recognized for its cardioprotective effects against DOX-induced cardiac inflammation, although the precise mechanisms remain incompletely understood. The activation of inflammasomes has been implicated in pathogenesis and treatment cardiotoxicity, nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome emerging as key mediator cardiovascular inflammation. This study aimed to investigate role modulating NLRP3 protect Male Sprague–Dawley rats were randomly assigned receive 10-day course DOX or saline injections, without preceding 10-week treadmill running regimen. Cardiovascular function histological changes subsequently evaluated. cardiotoxicity was characterized by atrophy, systolic dysfunction, hypotension, alongside inflammasome. Our findings revealed that regular preserved mass hypertrophic indices prevented it did not fully preserve blood pressure. These results underscore significant While entirely prevent our demonstrate confers protection suppressing heart, underscoring anti-inflammatory role. Further research should explore temporal dynamics interactions among exercise, pyroptosis, other pathways enhance translational applications medicine.

Language: Английский

Citations

0

Synergistic Effects of Ginsenoside Rb1 and Peroxiredoxin 6 in Enhancing Myocardial Injury Treatment through Anti-Inflammatory, Anti-Oxidative, and Anti-Apoptotic Mechanisms DOI Creative Commons
Runhong Mu, Yupeng Li, Yunhe Cui

et al.

Journal of Ginseng Research, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 1, 2024

Ginsenosides have notable bioactivity in treating cardiovascular diseases, but the mechanisms of their combined use with Peroxiredoxin 6 (PRDX6) myocardial injury remain unclear. This study explores synergistic effects Ginsenoside Rb1 (Gs-Rb1) and PRDX6, aiming to provide a theoretical foundation for therapeutic potential. We established rat model isoproterenol (ISO)-induced observed that combination therapy was more effective than single-drug treatments, as shown by ECG monitoring Masson staining. performed RNA sequencing (RNA-Seq) on group ISO group. The results indicated that, compared group, alleviated reducing inflammation, oxidative stress, apoptosis. Further analyses, including cell morphology, apoptosis rates, HE staining, ROS fluorescence intensity, inflammation-related proteins, confirmed successfully inhibited apoptosis, managed lessened inflammation. Combined treatment Gs-Rb1 PRDX6 significantly cardiac tissue fibrosis rats, leading marked decrease serum CK LDH levels. RNA-seq analysis revealed upregulated genes related lipid metabolism small molecule biosynthesis, while downregulated were associated Validation experiments treatment's significant inhibition activity, These support effectiveness two-drug suppressing key biological processes tissue, suggesting potential combating fibrosis. clarifies how work together protect against damage, demonstrating reduces stress. highlights new avenue developing ginseng-based treatments.

Language: Английский

Citations

0

Cracking the Code: Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review DOI Open Access

Birandra K. Sinha

Published: Dec. 18, 2023

In recent years, the emergence of cancer drug resistance is one crucial tumor hallmarks which supported by level genetic heterogeneity and complexities at cellular levels. Oxidative stress, immune evasion, metabolic reprogramming, overexpression ABC transporters stemness are among several key contributing molecular response mechanisms. Topo-active drugs, e.g., doxorubicin topotecan, clinically active utilized extensively against a wide variety human tumors often results in development failure to therapy. Thus, there an urgent need for incremental comprehensive understanding mechanisms specifically context topo-active drugs. This review delves into intricate mechanistic aspects these intracellular extracellular explores use potential combinatorial approaches utilizing various drugs inhibitors pathways involved resistance. We believe that this will help guide basic scientists, pre-clinicians, clinicians, policymakers toward holistic interdisciplinary strategies transcend resistance, renewing optimism ongoing battle cancer.

Language: Английский

Citations

1